CAMBRIDGE, MA, eGenesis, a biotechnology company developing human-compatible engineered organs to address the global organ shortage, today announced the close of a $191 million Series D financing.
Read More

BOSTON, MA, Aktis Oncology, a clinical-stage biotechnology company, announced the successful closing of an oversubscribed and upsized $175 million Series B financing.
Read More

BOSTON, MA, Superluminal Medicines announced the closing of a $120 million Series A funding round led by RA Capital.
Read More

SAN DIEGO, CA, Splitero announced today that it has a $300 million strategic.
Read More

DALLAS, TX, Perry Weather has secured $15 million in Series B funding from Arthur Ventures, which also led the company's Series A round.
Read More

HALLANDALE BEACH, FL, Solubag today announced new funding.
Read More

NEW YORK, NY, Today, Drop Protocol, a liquid staking protocol for Interchain assets and an inaugural member of the Lido Alliance, successfully closed a $4 million seed funding round.
Read More